GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.90 $2.80 Wednesday, 17th Apr 2024 CGEN stock ended at $1.90. This is 6.40% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 7.37% from a day low at $1.90 to a day high of $2.04.
90 days $1.80 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
2021-07-06 $8.02 $8.17 $7.61 $7.71 492 660
2021-07-02 $7.97 $8.17 $7.74 $8.02 796 724
2021-07-01 $8.29 $8.29 $7.83 $8.00 888 376
2021-06-30 $8.33 $8.52 $8.11 $8.28 1 094 850
2021-06-29 $8.67 $8.81 $8.25 $8.33 736 071
2021-06-28 $8.88 $9.20 $8.68 $8.70 1 371 517
2021-06-25 $8.58 $8.84 $8.34 $8.83 1 136 524
2021-06-24 $8.12 $8.89 $8.05 $8.47 2 361 956
2021-06-23 $7.71 $7.88 $7.69 $7.78 681 225
2021-06-22 $7.91 $7.95 $7.56 $7.67 486 029
2021-06-21 $7.85 $7.96 $7.60 $7.96 656 031
2021-06-18 $7.70 $8.01 $7.62 $7.82 815 868
2021-06-17 $7.56 $8.05 $7.50 $7.80 1 152 790
2021-06-16 $8.17 $8.17 $7.33 $7.60 1 148 678
2021-06-15 $8.44 $8.48 $7.88 $8.15 940 048
2021-06-14 $8.26 $8.86 $8.22 $8.51 1 847 037
2021-06-11 $8.35 $8.63 $7.92 $7.93 1 043 688
2021-06-10 $7.87 $8.39 $7.73 $8.34 1 827 312
2021-06-09 $7.66 $8.03 $7.66 $7.82 1 189 691
2021-06-08 $8.09 $8.33 $7.49 $7.66 1 018 418
2021-06-07 $7.29 $8.14 $7.24 $7.94 1 637 151
2021-06-04 $7.45 $7.48 $7.19 $7.23 813 273
2021-06-03 $7.60 $7.72 $7.30 $7.35 933 984
2021-06-02 $7.65 $7.89 $7.50 $7.73 769 385
2021-06-01 $7.77 $7.81 $7.50 $7.69 1 077 802
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT